The sales of Non-Steroids Antiinflammatory and Antirheumatic Medicines in Italy are forecasted to decline from 0.5% of total sales in 2024 to 0.3% in 2028. The consistent reduction between 2026 and 2028 reflects a broader trend starting from 2025. The year-on-year change between 2024 and 2025 indicates a 20% decrease. Further, from 2026 onwards, there is stabilization, followed by another 25% drop expected between 2027 and 2028. This pattern suggests an average annual decrease, as depicted by the CAGR over the five-year period.
Future trends to watch for include potential impacts from alternative treatments, price adjustments, and healthcare policy changes. These factors could further influence market dynamics and demand in Italy.
